Thymopoietin pentapeptide, 即TP-5,是一合成的戊肽表现有胸腺生成素的32-36残基.可诱导胸腺细胞成熟及影响T细胞和B细胞的分化.初步报告用于治疗类风湿性关节炎有效而安全,本文报告用TP-5治疗AD.共20例AD患者,其中14例尚有变应性呼吸道疾病,年龄自20～50岁(平均33岁).临床上按红斑、水疱、苔藓化、鳞屑、糜烂及瘙痒 Thymopoietin pentapeptide, or TP-5, is a synthetic pentamycine that exhibits thymopoietin residues 32-36, induces thymocyte maturation and affects the differentiation of T and B cells, and is primarily reported for the treatment of rheumatoid arthritis Efficacy and safety of inflammation, this article reports the use of TP-5 treatment of AD. A total of 20 cases of AD patients, of which 14 cases still have allergic respiratory disease, age from 20 to 50 years (mean 33 years old) .Clinical press erythema, blisters, Mossy, scaly, debilitated and itchy